amyotrophic lateral sclerosis (ALS)
FierceBiotech – Neuroscience drug discoverer Verge Genomics has raised $32 million in early venture capital financing, a large boost to its plans to bring its AI-generated compounds to the clinic against amyotrophic lateral sclerosis and Parkinson’s disease within the next three years.
University of Cambridge – Widely regarded as one of the world’s most brilliant minds, he was known throughout the world for his contributions to science, his books, his television appearances, his lectures and through biographical films.
Reuters – BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) at Massachusetts General Hospital and UC Irvine Medical Center in California.
In this week's Genetics / Genomics SciPol Weekly, a new pediatric genomic data program; actions toward stricter GMO food labeling; claims that Monsanto ghostwrote studies about Roundup's safety; and advances in liquid biopsies.
In this week's Neuroscience SciPol Weekly, another lawsuit aimed at opioid drug manufacturers; new rules in rugby for concussion assessments; a link between childhood TBI and alcohol abuse; and the brain cancer affecting many baseball players.
In this week's Neuroscience SciPol Weekly, new efforts to create a Zika vaccine; criminal challenges around opioid distribution; signs of brain injury in the blood of MMA fighters; and how white-collar jobs are linked with neurodegenerative diseases.
ESPN / The Associated Press – The payouts were for $5 million for a qualifying diagnosis of ALS (Lou Gehrig's disease) and $4 million for a qualifying diagnosis of CTE (chronic traumatic encephalopathy). The names of the former players were not disclosed.
In today's Neuroscience SciPol Daily, new research developments regarding neurons in ALS and Parkinson's; the growing popularity of flag football as a means to combat youth concussions; and societal impacts of the opioid epidemic.
In today's Neuroscience SciPol Daily, the single mutation that made Zika so prominent; questions about a new ALS therapy; new vaccines for brain cancer; linking individual neurons with movement; and the increasing number of Zika infections in Cuba.
In today's Genetics / Genomics SciPol Daily, researchers identified a new ALS gene variant; using gene therapy to better fix broken bones; and using a cancer drug to treat asthma.